| Thursday, October 30, 2025 | 
|  | 
            
| MHI and Nippon Shokubai to Develop Ammonia Cracking System for NEDO's "Development of Technologies for Building a Competitive Hydrogen Supply Chain" Project 
22:14 HKT/SGT |   | 
|  | 
| NEC and e& Sign MoU to Drive Joint Sustainability Initiatives 
21:46 HKT/SGT |   | 
|  | 
| MHI Thermal Systems Launches Two New Models of Air-to-Water Heat Pumps Using Natural Refrigerant R290 for European Market 
21:19 HKT/SGT |   | 
|  | 
| Decent Cybersecurity Highlights Slovakia's Tech Leadership at the EU-NZ Business Summit 
21:00 HKT/SGT |   | 
|  | 
| Hitachi Energy and Blackstone Energy Transition Partners enter strategic partnership to create leading energy service provider in North America 
20:40 HKT/SGT |   | 
|  | 
| CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China 
20:00 HKT/SGT |   | 
|  | 
| Esperanza Unveils New Milestone in Tokenized Economy 
19:09 HKT/SGT |   | 
|  | 
| MHI-MS to Conduct Demonstration Testing of Vehicle Transport Robots at Nakagusuku Port in Okinawa 
16:58 HKT/SGT |   | 
|  | 
| Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders 
16:48 HKT/SGT |   | 
|  | 
| DENSO Hosted a Press Briefing at JAPAN MOBILITY SHOW 2025 
16:29 HKT/SGT |   | 
|  | 
| Northeast Asia Video Summit Spotlights Global Content Strategies, Streaming Innovation, and the Future of Media Monetization 
15:00 HKT/SGT |   | 
|  | 
| Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma 
13:43 HKT/SGT |   | 
|  | 
| Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025 
13:33 HKT/SGT |   | 
|  | 
| Mazda Rolls Out New Version of Brand Symbol from Japan Mobility Show 2025 13:26 HKT/SGT
 |   | 
|  | 
| NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI 
13:18 HKT/SGT |   | 
|  | 
| Overview of Honda CEO Speech at the Japan Mobility Show 2025 
13:00 HKT/SGT |   | 
|  | 
| Reclaims Global Positions for Next Phase of Growth with Successful Placement and Strong Sector Momentum 11:14 HKT/SGT
 |   | 
|  | 
| Honda Presents World Premiere of the Prototype of Honda 0 a, new SUV Model for Honda 0 Series at Japan Mobility Show 2025 
10:55 HKT/SGT |   | 
|  | 
| Honda Presents World Premiere of Super-ONE Prototype Compact EV at Japan Mobility Show 2025 
10:50 HKT/SGT |   | 
|  | 
| Mitsubishi Motors Debuts Mitsubishi Elevance Concept and Adventure-Inspiring Lineup at Japan Mobility Show 2025 
10:39 HKT/SGT |   | 
|  | 
| Fujitsu and PwC Japan partner on economic security measures for sovereign cloud solution 
10:22 HKT/SGT |   | 
|  | 
| Hitachi Rail becomes world's first transportation firm to adopt new NVIDIA IGX Thor solution for real-time AI  
10:00 HKT/SGT |   | 
|  | 
| OTS Holdings Celebrates the Grand Opening of its New Manufacturing Facility, Ellaziq (Malaysia) Sdn. Bhd., in Johor, Malaysia; Marks Major Expansion in its Halal Production Capacity 
09:20 HKT/SGT |   | 
|  | 
            | Wednesday, October 29, 2025 | 
|  | 
            
| Ecological Threat Report 2025: Extreme Wet-Dry Seasons Emerge as Critical Conflict Catalyst 
13:00 HKT/SGT |   | 
|  | 
| GTJAI Assisted Deepexi Technology in Successfully Listing on the Main Board of the Hong Kong Stock Exchange 
10:30 HKT/SGT |   | 
|  | 
| GTJAI Serves as the Sole Sponsor for CIG, Achieving the Largest IPO in the Telecommunications Equipment Sector across Both A-shares and H-shares Markets 
10:27 HKT/SGT |   | 
|  | 
| Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center 
10:00 HKT/SGT |   | 
|  | 
| Gannon & Scott has signed a definitive agreement to join Metalor Technologies 
03:00 HKT/SGT |   | 
|  | 
            | Tuesday, October 28, 2025 | 
|  | 
            
| Merck & Co., Inc. and Eisai Announce WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma 
23:30 HKT/SGT |   | 
|  | 
| Mitsubishi Heavy Industries Machinery Systems to Exhibit at Japan Mobility Show 2025 
23:00 HKT/SGT |   | 
|  | 
|  | 
|  |